Molecular Modeling Studies on the Binding Mode of the PD-1/PD-L1 Complex Inhibitors
The programmed cell death protein 1 (PD-1)/programmed cell death ligand 1 (PD-L1) is an immune checkpoint (ICP) overexpressed in various types of tumors; thus, it has been considered as an important target for cancer therapy. To determine important residues for ligand binding, we applied molecular d...
Main Authors: | Suliman Almahmoud, Haizhen A. Zhong |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2019-09-01
|
Series: | International Journal of Molecular Sciences |
Subjects: | |
Online Access: | https://www.mdpi.com/1422-0067/20/18/4654 |
Similar Items
-
Advances of PD-1/PD-L1 Inhibitors in Tumor Immunotherapy
by: Yong-jun LIU, et al.
Published: (2017-06-01) -
Heat Shock Proteins and PD-1/PD-L1 as Potential Therapeutic Targets in Myeloproliferative Neoplasms
by: Steven De Almeida, et al.
Published: (2020-09-01) -
Research Progress of PD-1/PD-L1 Checkpoint Inhibitors in (Neo) Adjuvant Therapy for Malignant Melanoma
by: ZOU Hanhui, et al.
Published: (2020-02-01) -
PD-1/ PD-L1 blockade as a novel treatment for colorectal cancer
by: Neda Yaghoubi, et al.
Published: (2019-02-01) -
A Mini-Review for Cancer Immunotherapy: Molecular Understanding of PD-1/PD-L1 Pathway & Translational Blockade of Immune Checkpoints
by: Yongshu Li, et al.
Published: (2016-07-01)